Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Shares Issued (2017 - 2025)

Historic Shares Issued for Sutro Biopharma (STRO) over the last 9 years, with Q3 2025 value amounting to $126000.0.

  • Sutro Biopharma's Shares Issued changed N/A to $126000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $372000.0, marking a year-over-year decrease of 9947.99%. This contributed to the annual value of $71.5 million for FY2024, which is 49750.23% up from last year.
  • Sutro Biopharma's Shares Issued amounted to $126000.0 in Q3 2025.
  • Sutro Biopharma's 5-year Shares Issued high stood at $70.6 million for Q2 2024, and its period low was $126000.0 during Q3 2025.
  • In the last 5 years, Sutro Biopharma's Shares Issued had a median value of $1.0 million in 2022 and averaged $10.2 million.
  • In the last 5 years, Sutro Biopharma's Shares Issued tumbled by 9962.27% in 2021 and then soared by 2010625.0% in 2022.
  • Over the past 5 years, Sutro Biopharma's Shares Issued (Quarter) stood at $513000.0 in 2021, then skyrocketed by 2891.23% to $15.3 million in 2022, then crashed by 93.17% to $1.0 million in 2023, then skyrocketed by 6638.17% to $70.6 million in 2024, then tumbled by 99.82% to $126000.0 in 2025.
  • Its Shares Issued stands at $126000.0 for Q3 2025, versus $246000.0 for Q1 2025 and $70.6 million for Q2 2024.